ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

The University of Texas MD Anderson Cancer Center at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

The University of Texas MD Anderson Cancer Center brings 4 presentations to ACR Convergence 2026 in Orlando. Its program centres on rheumatic complications of cancer immunotherapy, including checkpoint inhibitor arthritis and Raynaud's phenomenon, with work on point-of-care ultrasound and air pollution in systemic sclerosis.

OrganizationACR Convergence 2026 Attendance
Hospitals and health systems
A cancer treatment and research center affiliated with The University of Texas System.
Talk
Sat Nov 7
10:00am–10:30am
Part of Basic Musculoskeletal Ultrasound Course II
Lecture B10: Curbside to Clinic: Point-of-Care Ultrasound for Real-Time Rheumatology Decisions
W109A
Imaging and ultrasound

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at The University of Texas MD Anderson Cancer Center

Tell us what you sell and we’ll find the people at The University of Texas MD Anderson Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction